-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-metaanalysis_methods.pdf
July 01, 2012 - choice of the model.19 For
example, “spectrum effects,” where the subjects included in a study are not representative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
February 10, 2010 - long-term (≥6
months) outcomes, with some
validity of case ascertainment or in
those with broadly representative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-research-depression.pdf
October 01, 2021 - submitting data, no affiliation)
• Resume/CV(s)
• Proof of Human Subjects Research training
Authorized representative … Registries
should also consider whether any additional parties, such as an institutional representative
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_disposition-comments.pdf
October 05, 2010 - orthopedic surgeon on
the TEP, one of the clinical leads of this project is an orthopedic
surgeon and a representative
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
December 01, 2014 - A representative from AHRQ served as a Contracting Officer’s Technical Representative and
provided
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0272_03-06-2008.pdf
January 01, 2008 - Effective Health Care
Topic Numbers: 0011b, 0039, 0083b
Document Completion Date: 5-19-09
1
Results of Topic Selection Process & Next Steps
Sleep apnea treatment will go forward for refinement as a comparative effectiveness or effectiveness
review. The scope of this topic, including popul…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
January 01, 2008 - Effective Health Care
Topic Number(s): 0087/0112
Document Completion Date: 6-26-09
1
Results of Topic Selection Process & Next Steps
Typical vs atypical antipsychotics will go forward for refinement as a comparative effectiveness or
effectiveness review. The scope of this topic, including p…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
December 27, 2016 - Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma
Evidence-based Practice Center Systematic Review Protocol
Amendment Date(s): November 18, 2016
(Amendment Details – …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
May 27, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 27, 2010
1
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness and Safety of Radio…
-
effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
January 01, 2013 - Covariate Selection for Observational Comparative Effectiveness Research
Covariate Selection for Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Covariate Selection for Observational Comparative Effectiveness Research
This slide set is b…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
January 01, 2013 - stage at the time of
the last search because draft reports have not been peer reviewed and may not be representative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-future_research.pdf
January 01, 2020 - HealthCare
Baltimore, MD
Selen Saydam
Patient Stakeholder
Columbia, MD
Lindsey Wilsnack
Employer Representative
-
effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
December 01, 2014 - A representative from AHRQ served as a Contracting Officer’s Technical Representative and
provided … Representative, private, third-party payers that include lomitapide in their drug formularies
typically … LAA occlusion with the Watchman device.
4
ECRI Institute routinely searches of a group of representative … Representative, private, third-party payers
that include lomitapide in their drug formularies have … patients with
degenerative MR disease are candidates for the procedure each year.128 At this time, six
representative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disabilities-quality-improvement-outcomes_research-protocol.pdf
August 03, 2011 - Evidence-based Practice Center Systematic Review Protocol
1
Source: www.effectivehealthcare.ahrq.gov
Published Online: August 3, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Closing the Quality Gap Series:
Measuring Outcomes of Care for Persons With Disabilities
I…
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - hesitant to identify themselves as
research funders due to concerns that their opinions would be seen as representative … hesitant to self-identify as research funders due to concerns that their opinions would be seen as
representative
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - ORIGINAL ARTICLE
Assessment of Adherence to and Persistence on
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Patients With Rheumatoid Arthritis
Carlos G. Grijalva, MD, MPH,* Cecilia P. Chung, MD, MPH,† Patrick G. Arbogast, PhD,*‡
Charles M. Stein, MD,† Edward F. Mitchel, Jr, MS,* and Marie R. Griffin, MD, MPH*§¶…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
January 01, 2007 - target population into 1 of 3 levels of
applicability that are defined as follows:
High
Sample is representative … Moderate
Sample is representative of a relevant subgroup of the target population, but not the entire … Low
Sample is representative of a narrow subgroup of subjects only, and is of limited applicability
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertensive-disorders-pregnancy-disposition-comments.pdf
May 31, 2023 - external reviewers, nine Technical Expert Panel (TEP) members, and one Key
Informant (KI)/patient representative